Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patent Expiration

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was first introduced by Teva Womens Health Inc in its drug Adderall 10 on Feb 13, 1996. Other drugs containing Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate are Adderall Xr 10, Adderall 7.5, Adderall Xr 5, Adderall Xr 25, Adderall 12.5, Mydayis, Adderall Xr 20, Adderall Xr 15, Adderall 15, Adderall 5, Adderall 20, Adderall 30, Adderall Xr 30. 32 different companies have introduced drugs containing Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate.

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patents

Given below is the list of patents protecting Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Mydayis	US8846100	Controlled dose drug delivery system	Aug 24, 2029	Takeda Pharms Usa
Mydayis	US9173857	Controlled dose drug delivery system	May 12, 2026	Takeda Pharms Usa
Mydayis	US6913768	Sustained release delivery of amphetamine salts	May 24, 2023 (Expired)	Takeda Pharms Usa
Adderall 10	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 12.5	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 15	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 20	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 30	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 5	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 7.5	US6384020 (Pediatric)	Rapid immediate release oral dosage form	Jan 06, 2021 (Expired)	Teva Womens
Adderall 10	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 12.5	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 15	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 20	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 30	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 5	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall 7.5	US6384020	Rapid immediate release oral dosage form	Jul 06, 2020 (Expired)	Teva Womens
Adderall Xr 10	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 10	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 10	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 10	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 15	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 15	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 15	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 15	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 20	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 20	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 20	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 20	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 25	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 25	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 25	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 25	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 30	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 30	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 30	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 30	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 5	US6322819 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 5	US6605300 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 5	USRE41148 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 5	USRE42096 (Pediatric)	Oral pulsed dose drug delivery system	Apr 21, 2019 (Expired)	Takeda Pharms Usa
Adderall Xr 10	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 10	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 10	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 10	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 15	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 15	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 15	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 15	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 20	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 20	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 20	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 20	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 25	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 25	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 25	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 25	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 30	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 30	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 30	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 30	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 5	US6322819	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 5	US6605300	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 5	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Adderall Xr 5	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Mydayis	USRE41148	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa
Mydayis	USRE42096	Oral pulsed dose drug delivery system	Oct 21, 2018 (Expired)	Takeda Pharms Usa

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Generic API Manufacturers

Several generic applications have been filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. The first generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was by Barr Laboratories Inc and was approved on Feb 11, 2002. And the latest generic version is by Lupin Inc and was approved on Nov 7, 2024.

Given below is the list of companies who have filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate generic, along with the locations of their manufacturing plants worldwide.

1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
5MG; 5MG; 5MG; 5MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Discontinued	ORAL	N/A	Nov 22, 2021

2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Jun 22, 2012
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Feb 5, 2016
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Feb 5, 2016

Manufacturing Plant Locations
^New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country

City

Firm Name

United States

Elizabeth

Actavis Elizabeth LLC, A Company of Teva

3. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Oct 6, 2023
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Oct 6, 2023

4. ALVOGEN

Alvogen Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jul 28, 2017
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Jul 28, 2017

Manufacturing Plant Locations
^New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country

City

Firm Name

United States

Morristown

Alvogen, Inc

5. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Jan 22, 2019

6. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Apr 22, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Apr 22, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Sep 29, 2021

7. AUROLIFE PHARMA LLC

Aurolife Pharma Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Aurolife Pharma Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Nov 27, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Nov 27, 2013
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	Jun 24, 2020

Manufacturing Plant Locations
^New

Aurolife Pharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurolife Pharma Llc as present at those locations.

Country

City

Firm Name

United States

Durham

Aurolife Pharma LLC

8. BARR

Barr Laboratories Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG (reference standard)	tablet	Prescription	ORAL	AB	Feb 11, 2002
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Feb 11, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Feb 11, 2002
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Feb 11, 2002
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Mar 19, 2003
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Mar 19, 2003
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Mar 19, 2003

Manufacturing Plant Locations
^New

Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.

Country

City

Firm Name

Mexico

Aldama

Barra La Coma, S. De R.L

Singapore

Barramundi Asia Pte Ltd

United States

Greenwood	Barr Enterprises, Inc.
Madison	Barriques Holding Company, LLC
Belvidere	Barred Woods, LLC
Commerce	Barreras Meat Co
Swartz Creek	Barrett Donut Mixes, Inc..
Forest	Barr Laboratories Inc.
Barrett	Barrett Farm Supply, Inc.
Randolph	Barrett Farm
Lee	Barrington Coffee Roasting Company, Inc.
Newton	Barrett Technology, LLC
Dillon	Barretts Minerals Inc
Montezuma	Barrington Dairies
Machipongo	Barrier Island Seafood
Live Oak	Barrington Dairy Farm
Hereford	Barrett and Crofoot Feedyard, West
Franklin	Barrett Distribution Centers, Inc.
Lake Barrington	Barrington Ventures, Ltd
Arecibo	Barreto Dairy, Inc.
Harrison	Barrington Chemical Corporation
Davie	Barrier Technologies LLC
Hereford	Barrett and Crofoot, LLP
Memphis	Barrett Distribution Centers
Englewood	Barrett E. Cowan, MD
Buffalo	Barrel and Brine Inc
Curtis Bay	Barrett Distribution Center
Paso Robles	Barreto Cellars
Brainerd	Barrett Ag Service, Inc.
Somerset	Barrett Distribution Centers Inc

Philippines

Bulacan

Barrio Fiesta Manufacturing Corporation

9. BARR LABS INC

Barr Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	Feb 12, 2013

10. CEDIPROF INC

Cediprof Inc has filed for 5 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Cediprof Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jul 5, 2022
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Jul 5, 2022
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jul 5, 2022
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jul 5, 2022
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Jul 5, 2022

11. ELITE LABS INC

Elite Laboratories Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Elite Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Dec 7, 2018
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Dec 7, 2018
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Dec 11, 2019

12. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	May 31, 2019

13. EPIC PHARMA LLC

Epic Pharma Llc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Jun 19, 2002
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jun 19, 2002
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jun 19, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jun 19, 2002
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Nov 3, 2014
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Nov 3, 2014
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Nov 3, 2014

14. GRANULES

Granules Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Granules.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Dec 28, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Dec 28, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Jan 23, 2023

Manufacturing Plant Locations
^New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country

City

Firm Name

United States

Chantilly	Granules Pharmaceuticals Inc.
Manassas	Granules Consumer Health Inc.

India

Secunderabad	Granules India Limited
Visakhapatnam	Granules India Limited
Parawada Mandal	Granules India Limited
Medchal-Malkhajgiri District	Granules India Limited
Sangareddy District	Granules India Limited

15. IMPAX LABS

Impax Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Feb 16, 2016

16. LANNETT CO INC

Lannett Co Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Nov 26, 2021
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Jul 8, 2022
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Jul 8, 2022

17. LUPIN

Lupin Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Lupin.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Nov 7, 2024

Manufacturing Plant Locations
^New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country

City

Firm Name

India

Mumbai	Lupin Limited
Anakapalli District	Lupin Manufacturing Solutions Limited
Vasco Da Gama	Lupin Limited
Dabhasa	LUPIN MANUFACTURING SOLUTIONS LIMITED
Mandideep	Lupin Limited (Unit II)
Pirangut	Lupin Limited
Tarapur, Thane	Lupin Limited
Pune	Lupin Bioresearch Center
Pithampur	Lupin Limited
Pithampur	Lupin Limited (Unit 1)
Mandideep	Lupin Limited
Nagpur	Lupin Limited
Navi Mumbai	LUPIN LIMITED
Aurangabad	Lupin Ltd.

United States

Baltimore	Lupin Pharmaceuticals Inc.
Coral Springs	Lupin Research Inc

18. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	Jul 17, 2019

19. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
5MG; 5MG; 5MG; 5MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Discontinued	ORAL	N/A	Nov 10, 2015

20. NUVO PHARM

Nuvo Pharmaceutical Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nuvo Pharm.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Dec 28, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Dec 28, 2017

Manufacturing Plant Locations
^New

Nuvo Pharm's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Nuvo Pharm as present at those locations.

Country

City

Firm Name

Canada

Varennes

Nuvo Pharmaceuticals Inc.

21. ORYZA

Oryza Pharmaceuticals Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Oryza.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Apr 3, 2020
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Apr 3, 2020
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Apr 3, 2020
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Apr 3, 2020
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Apr 3, 2020
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Apr 3, 2020

Manufacturing Plant Locations
^New

Oryza's manufacturing plants are situated in 1 country - Japan. Given below are the details of these plant locations as well as the firm names of Oryza as present at those locations.

Country

City

Firm Name

Japan

Ichinomiya

Oryza Oil & Fat Chemical Co., Ltd.

22. RHODES PHARMS

Rhodes Pharmaceuticals Lp has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Rhodes Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB1	May 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Jan 13, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Jan 13, 2021

23. SANDOZ

Sandoz Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Jun 14, 2002
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Jun 14, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Jun 14, 2002
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Sep 27, 2002

Manufacturing Plant Locations
^New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country

City

Firm Name

Austria

Kundl	Sandoz GmbH
Langkampfen	Sandoz GmbH

United States

East Hanover	Sandoz Incorporated
Princeton	Sandoz Inc

Spain

Les Franqueses Del Valles	Sandoz Industrial Products S.A.
Palafolls	Sandoz Industrial Products, S.A.

India

Navi Mumbai

Sandoz Private Limited

24. SPECGX LLC

Specgx Llc has filed for 10 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Specgx Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
3.125MG; 3.125MG; 3.125MG; 3.125MG	capsule, extended release	Prescription	ORAL	AB2	Aug 31, 2023
5MG; 5MG; 5MG; 5MG	capsule, extended release	Prescription	ORAL	AB1	Apr 22, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Prescription	ORAL	AB1	Apr 22, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Prescription	ORAL	AB1	Apr 22, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Oct 7, 2003
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Prescription	ORAL	AB1	Apr 22, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Prescription	ORAL	AB1	Apr 22, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB2	Aug 31, 2023
12.5MG; 12.5MG; 12.5MG; 12.5MG	capsule, extended release	Prescription	ORAL	AB2	Aug 31, 2023
9.375MG; 9.375MG; 9.375MG; 9.375MG	capsule, extended release	Prescription	ORAL	AB2	Aug 31, 2023

Manufacturing Plant Locations
^New

Specgx Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Specgx Llc as present at those locations.

Country

City

Firm Name

United States

Saint Louis	SpecGx LLC
Raleigh	SpecGx LLC
Greenville	SpecGx LLC

25. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
12.5MG; 12.5MG; 12.5MG; 12.5MG	capsule, extended release	Prescription	ORAL	AB2	Sep 27, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG	capsule, extended release	Prescription	ORAL	AB2	Sep 27, 2023
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB2	Sep 27, 2023
9.375MG; 9.375MG; 9.375MG; 9.375MG	capsule, extended release	Prescription	ORAL	AB2	Sep 27, 2023

26. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Sep 9, 2003
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Sep 9, 2003
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	May 17, 2019

27. TEVA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013
5MG; 5MG; 5MG; 5MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013
3.75MG; 3.75MG; 3.75MG; 3.75MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013
7.5MG; 7.5MG; 7.5MG; 7.5MG	capsule, extended release	Discontinued	ORAL	N/A	Apr 29, 2013

Manufacturing Plant Locations
^New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country

City

Firm Name

United States

Malvern	Teva Branded Pharmaceutical Products R&D, Inc.
Miami	Teva Branded Pharmaceutical Products R & D, Inc.
Horsham	Teva Branded Pharmaceutical Products R&D
Fort Dodge	TEVA Animal Health Inc

India

Bhind	Teva API India Ltd- Malanpur
Gajraula, Amroha	Teva API India Private Ltd.

Canada

Markham	Teva Canada Limited
Stouffville	Teva Canada Limited
Scarborough	Teva Canada Limited

Czech Republic

Opava

Teva Czech Industries s.r.o.

Ireland

Dundalk

Teva Laboratories Ireland Ltd

Israel

Kiryat-Shmona

TEVA Medical Ltd.

28. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Discontinued	ORAL	N/A	Sep 30, 2003
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Discontinued	ORAL	N/A	Sep 30, 2003
5MG; 5MG; 5MG; 5MG	tablet	Discontinued	ORAL	N/A	Sep 30, 2003
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Discontinued	ORAL	N/A	Sep 30, 2003

29. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
6.25MG; 6.25MG; 6.25MG; 6.25MG	capsule, extended release	Prescription	ORAL	AB2	Jan 31, 2022
9.375MG; 9.375MG; 9.375MG; 9.375MG	capsule, extended release	Prescription	ORAL	AB2	Jan 31, 2022
12.5MG; 12.5MG; 12.5MG; 12.5MG	capsule, extended release	Prescription	ORAL	AB2	Jan 31, 2022
3.125MG; 3.125MG; 3.125MG; 3.125MG	capsule, extended release	Prescription	ORAL	AB2	Jan 31, 2022

30. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
3.125MG; 3.125MG; 3.125MG; 3.125MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
3.75MG; 3.75MG; 3.75MG; 3.75MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
5MG; 5MG; 5MG; 5MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG	tablet	Prescription	ORAL	AB	Oct 31, 2017
2.5MG; 2.5MG; 2.5MG; 2.5MG	tablet	Prescription	ORAL	AB	Oct 31, 2017

Pharsight

Pharsight

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patents

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate's Family Patents

Explore Our Curated Drug Screens

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Generic API Manufacturers

1. ACCORD HLTHCARE

2. ACTAVIS ELIZABETH

Manufacturing Plant Locations New

3. ALKEM LABS LTD

4. ALVOGEN

Manufacturing Plant Locations New

5. ANI PHARMS

6. ASCENT PHARMS INC

7. AUROLIFE PHARMA LLC

Manufacturing Plant Locations New

8. BARR

Manufacturing Plant Locations New

9. BARR LABS INC

10. CEDIPROF INC

11. ELITE LABS INC

12. ENDO OPERATIONS

13. EPIC PHARMA LLC

14. GRANULES

Manufacturing Plant Locations New

15. IMPAX LABS

16. LANNETT CO INC

17. LUPIN

Manufacturing Plant Locations New

18. NESHER PHARMS

19. NORVIUM BIOSCIENCE

20. NUVO PHARM

Manufacturing Plant Locations New

21. ORYZA

Manufacturing Plant Locations New

22. RHODES PHARMS

23. SANDOZ

Manufacturing Plant Locations New

24. SPECGX LLC

Manufacturing Plant Locations New

25. SUN PHARM INDS INC

26. SUN PHARM INDUSTRIES

27. TEVA

Manufacturing Plant Locations New

28. TEVA PHARMS

29. TEVA PHARMS USA

30. ZYDUS PHARMS

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New